| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 10/14/2004 | WO2003075945A3 Cg8327, cg10823, cg18418, cg15862, cg3768, cg11447 and cg16750 homologous proteins involved in the regulation of energy homeostasis |
| 10/14/2004 | WO2003065985A3 Uses of mammalian cytokine; related reagents |
| 10/14/2004 | WO2002064732A8 POLYNUCLEOTIDE ENCODING A NOVEL HUMAN POTASSIUM CHANNEL ALPHA-SUBUNIT, K+alphaM1, AND VARIANTS THEREOF |
| 10/14/2004 | US20040204381 method of treating brain cancer in which tumor cell is transfected either ex vivo or in vivo with a composition comprising a DNA molecule that encodes a protein having glycosyltransferase activity resulting in inhibition of the growth or function of that cell |
| 10/14/2004 | US20040204376 Focal calcium channel modulation |
| 10/14/2004 | US20040204375 Gene delivery compounds |
| 10/14/2004 | US20040204374 oncogene switching therapeutics that are composed of sequence-specific nucleic acid decoys; these kinds of nucleic acids can competitively combine with certain transcription factors and regulate expression of proto-oncogenes such as C-FOS, C-JUN and C-MYC, leading to inhibition of tumor cell growth |
| 10/14/2004 | US20040204361 Kdel receptor inhibitors |
| 10/14/2004 | US20040204360 a nucleotide sequence encoding a protein of the ONECUT family characterized by the presence of a single CUT domain and the presence of an F48M50 dyad in the homeo domain for the treatment or for the prevention of diabetes or cancer, in particular to a genetic/cellular therapy |
| 10/14/2004 | US20040204358 Reducing culling in herd animals growth hormone releasing hormone (GHRH) |
| 10/14/2004 | US20040204350 Disease- associated protein |
| 10/14/2004 | US20040204345 Using recombinant zinc finger proteins; use in human therapeutic applications such as cancer therapy and altering plant phenotypes, including disease resistance, fruit ripening |
| 10/14/2004 | US20040203158 Transposon-insulator element delivery systems |
| 10/14/2004 | US20040203157 Transfroming arabidopsis with expression vector coding genes associated with heat, freeze, salt and drought resistance; using ribonucleoproteins to control effivient gene transcription in plants; bioreactors |
| 10/14/2004 | US20040203155 Methods for transfecting T cells |
| 10/14/2004 | US20040203154 Process for generating multilayered particles |
| 10/14/2004 | US20040203153 Procedure for specific replacement of a copy of a gene present in the recipient genome by the integration of a gene different from that where the integration is made |
| 10/14/2004 | US20040203152 Using serine recombinase as nucleotide sequence insertional tool for generating transgenic cells, tissues or plants; site specific recombination and gene therapy |
| 10/14/2004 | US20040203128 Use of PP2A phosphatase modulators in the treatment of mental disorders |
| 10/14/2004 | US20040203124 Electrodes coated with treating agent and uses thereof |
| 10/14/2004 | US20040203118 Polynucleotides and polypeptides of the IFNalpha-14 gene |
| 10/14/2004 | US20040203111 UDP-N-acetylglucosamine: galactose-B1,3-N-acetylgalactosamine-a-R/ (GlcNAc to GalNAc) B1-6 N- acetylglucosaminyltransferase, C2GnT3 |
| 10/14/2004 | US20040203107 Methods and compositions for grafting functional loops into a protein |
| 10/14/2004 | US20040203100 provides a family of antibodies that specifically bind the human cell surface glycosphingolipid GD2 for treating cancer by administering in vitro; genetic engineering |
| 10/14/2004 | US20040203098 Compounds and methods for modulating activation of NF-kappaB |
| 10/14/2004 | US20040203092 UDP-N-acetylglucosamine:galactose-beta1,3-N-acetylgalactosamine-alpha-R/ (GlcNAc to GalNAc) beta1-6 N-acetylglucosaminyltransferase, C2GnT3 |
| 10/14/2004 | US20040203087 screening gene expression inhibition via incubating mrna, determining expression in presence of test compound, then comparing levels; gene knockout |
| 10/14/2004 | US20040203066 Identifying modulator of progression elevated gene-3 (PEG-3) for use in treatment and prevention of antitumor/antiproliferative/antisense agents; peptide mimetic |
| 10/14/2004 | US20040203039 Attenuated salmonella SP12 mutants as antigen carriers |
| 10/14/2004 | US20040203024 Modified oligonucleotides for use in RNA interference |
| 10/14/2004 | US20040202999 for drug screening treatments for human immunodeficiency virus (HIV), cancer; gene therapy; long terminal repeat sequences; genetic engineering |
| 10/14/2004 | US20040202720 Delivery of immune response modifier compounds using metal-containing particulate support materials |
| 10/14/2004 | US20040202659 A polypeptide encoded by a nucleic acid that encodes a heavy chain, which is able to bind to GPIIb/IIIa, of a human antibody and comprising a CDR3 region; diagnosis, treatment or prevention of autoimmune thrombocytopenic purpura; modulating blood coagulation |
| 10/14/2004 | US20040202652 Methods and compositions for control of bone formation via modulation of leptin activity |
| 10/14/2004 | US20040202642 E.g., treating or preventing Parkinson's disease or symptoms or associated physiology such as motor deficits or nigrostriatal degeneration inducing nigrostriatal regeneration; especially a vector that expresses GDNF |
| 10/14/2004 | DE10295684T9 Verfahren zum spezifischen Hemmen von Histon-Deacetylase-4 Method for the specific inhibition of histone deacetylase 4 |
| 10/14/2004 | CA2520460A1 Use of fgf- 18 protein, target proteins and their respective encoding nucleotide sequences to induce cartilage formation |
| 10/13/2004 | EP1466624A1 Drug for regenerating tissue and vessel and method therefor |
| 10/13/2004 | EP1466618A1 Treatment for diabetes |
| 10/13/2004 | EP1466616A2 Use of CASB616 polypeptides and polynucleotides for cancer treatment |
| 10/13/2004 | EP1466001A2 Viruses with enhanced lytic potency medikament |
| 10/13/2004 | EP1465997A2 Use of biomolecular targets in the treatment and visualization of tumors |
| 10/13/2004 | EP1465995A1 Bispecific antisense olignucleotides that inhibit igfbp-2 and igfbp-5 and methods of using same |
| 10/13/2004 | EP1465924A2 Modulators of notch ic protease activity for use in immunotherapy |
| 10/13/2004 | EP1465912A2 Novel chimeric tnf ligands |
| 10/13/2004 | EP1465906A1 Compositions and methods relating to endometrial specific genes and proteins |
| 10/13/2004 | EP1465664A1 Stabilized formulations of adenovirus |
| 10/13/2004 | EP1465656A2 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR GnRH-I AND GnRH-II MODULATION OF T-CELL ACTIVITY, ADHESION, MIGRATION AND EXTRAVASATION |
| 10/13/2004 | EP1465654A2 Plasmid mediated suplementation for treating chronically ill subjects |
| 10/13/2004 | EP1465651A1 Use of c-jun or c-jun activating agents such as uv or c-jun n-terminal kinases (junks) for treating cancer |
| 10/13/2004 | EP1465650A2 Sk-3 potassium channels and the treatment of sexual dysfunctions and/or vascular disorders |
| 10/13/2004 | EP1465634A2 Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation |
| 10/13/2004 | EP1465599A1 Liposome composition for delivery of nucleic acid |
| 10/13/2004 | EP1465521A2 System and method for the pretreatment of the endplates of an intervertebral disc |
| 10/13/2004 | EP1465489A2 Methods of expressing lim mineralization protein in non-osseous cells |
| 10/13/2004 | EP1465481A1 Knockout swine and methods for making the same |
| 10/13/2004 | EP1154786B1 Compositions for altering mucus secretion |
| 10/13/2004 | EP1102858B1 Cell lines for the propagation of mutated herpes viruses |
| 10/13/2004 | EP1012291B1 Multiple site delivery of adenoviral vector for the induction of angiogenesis |
| 10/13/2004 | EP0921821B1 2-methoxyestradiol-induced apoptosis in cancer cells |
| 10/13/2004 | EP0817847B1 Il-17 receptor |
| 10/13/2004 | EP0719147B1 Gene therapy for solid tumors, papillomas and warts |
| 10/13/2004 | EP0595838B1 Tumor rejection antigen precursors, tumor rejection antigens and uses thereof |
| 10/13/2004 | CN1537173A Tools for diagnosis, molecular definition and development of treatment of chronic inflammatory joint diseases |
| 10/13/2004 | CN1537167A Von willebrand factor (VWF)-cleaving enzyme |
| 10/13/2004 | CN1537161A Antigen presenting cells, method for their preparation and their use for cancer vaccines |
| 10/13/2004 | CN1536083A Low virulent vero strain |
| 10/13/2004 | CN1536074A Method for genetically modifying and inducing intracerebral transplantation mesenchymal stem cells to be differentitated into neuron |
| 10/13/2004 | CN1535729A Tumor gene vaccine based on ectopic chorionic gonadotropin beta and its preparation method |
| 10/13/2004 | CN1535726A Molecular adjuvant, its preparation and gene vaccine containing said molecular adjuvant |
| 10/13/2004 | CN1535725A Viral myocarditis gene vaccine, its preparation method and application |
| 10/13/2004 | CN1170941C Human BMP-7 promoter and method for exploring bone-related substance by using the same |
| 10/13/2004 | CN1170849C Connective tissue growth factor fragments and methods and uses thereof |
| 10/12/2004 | US6803453 Using antibodies directed to a novel class or family of transforming growth factor (tgf)-beta binding proteins; for diagnosis, prevention, treatment of osteoporosis |
| 10/12/2004 | US6803450 Fusion protein; genetic engineering; energy storage |
| 10/12/2004 | US6803361 Administering nucleotide sequence |
| 10/12/2004 | US6803360 Resistance to said radiation or drug treatment is not a result of overexpression of her-2, comprising introducing into said cell an antisense nucleic acid |
| 10/12/2004 | US6803234 Expression vector for use in the transduction of human chondrocyte; obtain chondrocytes, incubate with expression vector, monitor cell for expression of reporter molecule |
| 10/12/2004 | US6803211 Cancer therapy |
| 10/12/2004 | US6803199 Thyroid sodium/iodide symporter and nucleic acid encoding same |
| 10/12/2004 | US6803198 Carbamate-derivatized nucleosides and oligonucleosides |
| 10/12/2004 | US6803189 Methods for the detection of cervical cancer |
| 10/12/2004 | US6803053 Condensed nucleic acid/lipid complex for increasing shelf life and high transfection activity in vivo following intravenous injection |
| 10/07/2004 | WO2004085673A2 Compositions and methods of using hexokinase v |
| 10/07/2004 | WO2004085659A2 Mutant vesicular stomatitis viruses and uses thereof |
| 10/07/2004 | WO2004085658A1 Mutant vesicular stomatitis viruses and use thereof |
| 10/07/2004 | WO2004085645A1 Rna interference in fish |
| 10/07/2004 | WO2004085623A2 A compact synthetic expression vector comprising double-stranded dna molecules and methods of use thereof |
| 10/07/2004 | WO2004085468A2 Human p53 splice variant displaying differential transcriptional activity |
| 10/07/2004 | WO2004084951A2 A method and vectors for selectively transducing retinal pigment epithelium cells |
| 10/07/2004 | WO2004084945A1 Eating controllers |
| 10/07/2004 | WO2004084930A1 Use of saposin-related proteins for preventing and treating obesity, diabetes and/or metabolic syndrome |
| 10/07/2004 | WO2004084837A2 Methods and compositions for treating and preventing inflammatory conditions |
| 10/07/2004 | WO2004067701A3 Improved genetic elements providing high levels of expression |
| 10/07/2004 | WO2004066908A3 Composition containing cationic lipids and a polynucleotide or a polypeptide and method for the targeted delivery of active substances |
| 10/07/2004 | WO2004013279A3 Helix-hairpin-helix motifs to manipulate properties of dna processing enzymes |
| 10/07/2004 | WO2004007678B1 Codon optimized synthetic plasmids |
| 10/07/2004 | WO2003101386A3 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis |
| 10/07/2004 | WO2003070768A3 Cd40 splice variants,method of detection thereof, compositions comprising said variant(s) or nucleic acid encoding the same and use thereof |
| 10/07/2004 | WO2002100250A8 Wit 3.0, a novel gene to control soft tissue wound healing |